Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction

Journal of Investigative Dermatology

Volumn 119, Issue 4, 2002, Pages 850-857

  Buentke, Eva ^a   Heffler, Lena C ^a   Wilson, Julia L ^b   Wallin, Robert P A ^b   Loöfman, Carl ^a   Chambers, Benedict J ^b   Ljunggren, Hans Gustaf ^b   Scheynius, Annika ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell communication; Cell death; Eczema

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN;

ARTICLE; ATOPIC DERMATITIS; ATOPY; CELL ASSAY; CELL DEATH; CELL INTERACTION; CONTROLLED STUDY; DENDRITIC CELL; HEALTH STATUS; HUMAN; HUMAN TISSUE; INCUBATION TIME; MALASSEZIA; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0036429954     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.00132.x     Document Type: Article

References (46)

1. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G: Atopy in children of families with an anthroposophic lifestyle. Lancet 353:1485-1488, 1999
2. Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811, 2000
3. Bouloc A, Charue D, Nikolova M, Bensussan A: No modulation of circulating natural killer cell and natural killer receptor bearing memory T cell subsets in patients with atopic dermatitis. J Invest Dermatol 115:1160-1162, 2000
4. Buentke E, Zargari A, Heffler LC, Avila-Carino J, Savolainen J, Scheynius A: Uptake of the yeast Malassezia furfur and its allergenic components by human immature CD1a+ dendritic cells. Clin Exp Allergy 30:1759-1770, 2000
5. Buentke E, Heffler LC, Wallin RP, Lofman C, Ljunggren HG, Scheynius A: The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy 31:1583-1593, 2001
6. Carbone E, Terrazzano G, Ruggiero G, et al: Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 29:4022-4029, 1999
7. Chambers BJ, Salcedo M, Ljunggren HG: Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311-317, 1996
8. Chiarelli F, Canfora G, Verrotti A, Amerio P, Morgese G: Humoral and cellular immunity in children with active and quiescent atopic dermatitis. Br J Dermatol 116:651-660, 1987
9. Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102:128-137, 1994
10. Eriksson M, Leitz G, Fallman E, Axner O, Ryan JC, Nakamura MC, Sentman CL: Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 190:1005-1012, 1999
11. Faergemann J: Pityrosporum species as a cause of allergy and infection. Allergy 54:413-419, 1999
12. Ferlazzo G, Semino C, Melioli G: HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 76:37-41, 2001
13. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343-351, 2002
14. Fernandez NC, Lozier A, Flament C, et al: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405-411, 1999
15. Geldhof AB, Moser M, Lespagnard L, Thielemans K, De Baetselier P: Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 91:196-206, 1998
16. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327-333, 2002
17. +CD3(-) NK cells: A regulatory role of monocytes and IL-10. J Immunol 165:139-147, 2000
18. Granucci F, Vizzardelli C, Pavelka N, et al: Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol 2:882-888, 2001
19. Grufman P, Kärre K: Innate and adaptive immunity to tumors: IL-12 is required for optimal responses. Eur J Immunol 30:1088-1093, 2000
20. Hashiro M, Okumura M: The relationship between the psychological and immunological state in patients with atopic dermatitis. J Dermatol Sci 16:231-235, 1998
21. ISAAC: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351:1225-1232, 1998
22. Johansson C, Eshaghi H, Tengvall Linder M, Jacobson E, Scheynius A: Positive atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with a Th2-like PBMC response. J Invest Dermatol 118:1044-1051, 2002
23. Johansson SGO, Hourihane JO, Bousquet J, et al: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56:813-824, 2001
24. Johnson GD, Davidson RS, McNamee KC, Russell G, Goodwin D, Holborow EJ: Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J Immunol Meth 55:231-242, 1982
25. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S: Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP- 1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293:350-355, 2001
26. Korsgren M, Persson CG, Sundler F, et al: Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med 189:553-562, 1999
27. Lesko MJ, Lever RS, Mackie RM, Parrott DM: The effect of topical steroid application on natural killer cell activity. Clin Exp Allergy 19:633-636, 1989
28. Leung DY: Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860-876, 2000
29. Mayser P, Gross A: IgE antibodies to Malassezia furfur, M. sympodialis and Pityrosporum orbiculare in patients with atopic dermatitis, seborrheic eczema or pityriasis versicolor, and identification of respective allergens. Acta Derm Venereol 80:357-361, 2000
30. Minter RM, Ferry MA, Rectenwald JE, et al: Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy. Proc Natl Acad Sci USA 98:277-282, 2001
31. Moretta A, Bottino C, Vitale M, et al: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197-223, 2001
32. Nakamura S, Suchi T, Koshikawa T, et al: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 19:284-296, 1995
33. Piccioli D, Sbrana S, Melandri E, Valiante NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195:335-341, 2002
34. Romani N, Gruner S, Brang D, et al: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93, 1994
35. Romani N, Reider D, Heuer M, et al: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Meth 196:137-151, 1996
36. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118, 1994
37. Scheynius A, Johansson C, Buentke E, Zargari A, Tengvall Linder M: Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Dermatol 127:161-169, 2002
38. Spaggiari GM, Carosio R, Pende D, et al: NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 31:1656-1665, 2001
39. Strannegárd IL, Strannegárd Ö.: Natural killer cells and interferon production in atopic dermatitis. Acta Dermato-Venereologica Suppl 92:48, 1980
40. Tengvall Linder M, Johansson C, Scheynius A, Wahlgren C: Positive atopy patch test reactions to Pityrosporum orbiculare in atopic dermatitis patients. Clin Exp Allergy 30:122-131, 2000
41. Vulcano M, Albanesi C, Stoppacciaro A, et al: Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 31:812-822, 2001
42. Wehrmann W, Reinhold U, Kukel S, Franke N, Uerlich M, Kreysel HW: Selective alterations in natural killer cell subsets in patients with atopic dermatitis. Int Arch Allergy Appl Immunol 92:318-322, 1990
43. Werfel T, Kapp A: Environmental and other major provocation factors in atopic dermatitis. Allergy 53:731-739, 1998
44. Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG: Targeting of human dendritic cells by autologous NK cells. J Immunol 163:6365-6370, 1999
45. Zachary CB, Allen MH, MacDonald DM: In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 112:149-156, 1985
46. + dendritic cells. Proc Natl Acad Sci USA 93:2588-2592, 1996